Human T Cell and Antibody-Mediated Responses to theMycobacterium tuberculosisRecombinant 85A, 85B, and ESAT-6 Antigens

How tumour necrosis factor blockers interfere with tuberculosis immunity

(2010) J. Harris et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Enhanced T cell responsiveness to Mycobacterium bovis BCG r32-kDa Ag correlates with successful anti-tuberculosis treatment in humans

(2010) V. Hari Sai Priya et al.   CYTOKINE

Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection

(2010) Nadia Caccamo et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Increased IgG1, IFN-γ, TNF-α and IL-6 responses to Mycobacterium tuberculosis antigens in patients with Tuberculosis are lower after chemotherapy

(2010) Ana Márcia M. Mattos et al.   INTERNATIONAL IMMUNOLOGY

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

(2010) Jaap T. van Dissel et al.   VACCINE

In Vitro Levels of Interleukin 10 (IL-10) and IL-12 in Response to a Recombinant 32-Kilodalton Antigen of Mycobacterium bovis BCG after Treatment for Tuberculosis

(2008) V. H. Sai Priya et al.   Clinical and Vaccine Immunology

Comparison of Sensitivities of Two Commercial Gamma Interferon Release Assays for Pulmonary Tuberculosis

(2008) C. B. E. Chee et al.   JOURNAL OF CLINICAL MICROBIOLOGY